Cargando…

Next generation sequencing for neurological diseases: New hope or new hype?

Over the past year huge advances have been made in our ability to determine the genetic aetiology of many neurological diseases through the utilisation of next generation sequencing platforms. This technology is, on a daily basis, providing new breakthroughs in neurological disease. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Keogh, M.J., Chinnery, P.F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694302/
https://www.ncbi.nlm.nih.gov/pubmed/23200550
http://dx.doi.org/10.1016/j.clineuro.2012.09.030
_version_ 1782274845625548800
author Keogh, M.J.
Chinnery, P.F.
author_facet Keogh, M.J.
Chinnery, P.F.
author_sort Keogh, M.J.
collection PubMed
description Over the past year huge advances have been made in our ability to determine the genetic aetiology of many neurological diseases through the utilisation of next generation sequencing platforms. This technology is, on a daily basis, providing new breakthroughs in neurological disease. The aim of this article is to clearly describe the technological platforms, methods of data analysis, established breakthroughs, and potential future clinical and research applications of this innovative and exciting technique which has relevance to all those working within clinical neuroscience.
format Online
Article
Text
id pubmed-3694302
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-36943022013-07-01 Next generation sequencing for neurological diseases: New hope or new hype? Keogh, M.J. Chinnery, P.F. Clin Neurol Neurosurg Article Over the past year huge advances have been made in our ability to determine the genetic aetiology of many neurological diseases through the utilisation of next generation sequencing platforms. This technology is, on a daily basis, providing new breakthroughs in neurological disease. The aim of this article is to clearly describe the technological platforms, methods of data analysis, established breakthroughs, and potential future clinical and research applications of this innovative and exciting technique which has relevance to all those working within clinical neuroscience. Elsevier 2013-07 /pmc/articles/PMC3694302/ /pubmed/23200550 http://dx.doi.org/10.1016/j.clineuro.2012.09.030 Text en © 2013 Elsevier B.V. https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license
spellingShingle Article
Keogh, M.J.
Chinnery, P.F.
Next generation sequencing for neurological diseases: New hope or new hype?
title Next generation sequencing for neurological diseases: New hope or new hype?
title_full Next generation sequencing for neurological diseases: New hope or new hype?
title_fullStr Next generation sequencing for neurological diseases: New hope or new hype?
title_full_unstemmed Next generation sequencing for neurological diseases: New hope or new hype?
title_short Next generation sequencing for neurological diseases: New hope or new hype?
title_sort next generation sequencing for neurological diseases: new hope or new hype?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694302/
https://www.ncbi.nlm.nih.gov/pubmed/23200550
http://dx.doi.org/10.1016/j.clineuro.2012.09.030
work_keys_str_mv AT keoghmj nextgenerationsequencingforneurologicaldiseasesnewhopeornewhype
AT chinnerypf nextgenerationsequencingforneurologicaldiseasesnewhopeornewhype